Understanding chromosome aberrations through cytogenomic analysis is an integral part of current genomic medicine, playing a role in both constitutional disorders and cancer. At Illumina, we collaborate with industry experts, thought leaders, and customers to develop next-generation sequencing (NGS) solutions to meet your evolving needs. Now you can perform sequencing and high-quality cytogenomic array scanning all on a single platform.
Advance your research with the flexible power of the NextSeq 550 System. Now you can perform sequencing and high-quality cytogenomic array scanning all on a single system. The BeadChip array adapter enables array scanning on the new NextSeq 550 System.
NGS offers detection that complements arrays. Together, the two methods are ideal across a spectrum of reproductive and genetic health applications.
Traditional molecular cytogenomic methods for assessing chromosomal abnormalities, including FISH and karyotyping, enable genome visualization, but often at a low resolution. As a result, data from these methods can often be inconsistent.
Cytogenomic microarrays offer a simpler, more reliable method for assessing chromosomal aberrations at a higher resolution.
Illumina offers industry-leading chromosomal microarrays designed to detect chromosome aberrations and provide accurate, reliable cytogenomic data with:
Perform sequencing and high-quality cytogenomic array scanning all on a single system, the NextSeq 550 System.
Learn More »
Learn more about how NGS is transforming research.
Access PDF »
iScan offers a dramatic reduction in microarray scanning time.
View system »
Analyze molecular cytogenomic data in a single framework.
View software »